
Manipal Hospitals is gearing up to file its Draft Red Herring Prospectus (DRHP) with SEBI for an initial public offering (IPO) valued at over ₹9,000 crore, as per news reports. The hospital chain, backed by Temasek Holdings, is eyeing a valuation of ₹1.2 lakh crore.
The upcoming IPO of Manipal Hospitals is expected to be one of the largest in India's healthcare sector.
The offering will include both an offer for sale and a fresh issue of shares. Despite current market volatility, the company is moving forward with its plans, reflecting the growing investor interest in the healthcare sector.
Manipal Hospitals is targeting a valuation of ₹1.2 lakh crore, potentially making it India's most valuable healthcare operator post-listing.
This development comes at a time when the IPO market has slowed, with many companies delaying their launches due to cautious investor sentiment and geopolitical tensions.
Manipal Hospitals has been expanding aggressively through strategic acquisitions, including the recent purchase of Sahyadri Hospitals.
In June, KKR announced a $600 million financing package to support Manipal's growth ambitions. This acquisition strategy is part of the company's broader plan to strengthen its position in the healthcare sector.
Read More: Innovision IPO Price Band Reduced Deadline Extended!
As part of a diversified conglomerate, Manipal Hospitals operates more than 10,500 beds across its network.
The company has a significant presence in the healthcare sector, with interests also spanning education and insurance. Currently, Max Healthcare Institute holds the title of India's most valuable hospital chain.
Manipal Hospitals' planned ₹9,000 crore IPO marks a significant move in the Indian healthcare sector. With a targeted valuation of ₹1.2 lakh crore, the company is set to become a key player in the industry. The IPO comes amidst a challenging market environment, highlighting the company's confidence in its growth strategy.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Mar 18, 2026, 1:19 PM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
